Please use this identifier to cite or link to this item:
http://archive.cmb.ac.lk:8080/xmlui/handle/70130/457
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rajapakse, S. | - |
dc.contributor.author | Rodrigo, C. | - |
dc.contributor.author | Rajapakse, A. | - |
dc.contributor.author | Kirthinanda, D. | - |
dc.contributor.author | Wijeratne, S. | - |
dc.date.accessioned | 2011-11-21T10:58:02Z | - |
dc.date.available | 2011-11-21T10:58:02Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | Saudi J Kidney Dis Transpl. 2009 Jul;20(4):553-9 | en_US |
dc.identifier.uri | http://archive.cmb.ac.lk:8080/xmlui/handle/70130/457 | - |
dc.description.abstract | Acute renal failure (ARF) is a common complication of sepsis and carries a high mortality. Renal replacement therapy (RRT) during the acute stage is the mainstay of therapy. Va-rious modalities of RRT are available. Continuous RRT using convective methods are preferred in sepsis-induced ARF, especially in hemodynamically unstable patients, although clear evidence of benefit over intermittent hemodialysis is still not available. Peritoneal dialysis is clearly inferior, and is not recommended. Early initiation of RRT is probably advantageous, although the optimal timing of dialysis is yet unknown. Higher doses of RRT are more likely to be beneficial. Use of bio-compatible membranes and bicarbonate buffer in the dialysate are preferred. Anticoagulation during dialysis must be carefully adjusted and monitored. | en_US |
dc.language.iso | en | en_US |
dc.title | Renal replacement therapy in sepsis-induced acute renal failure | en_US |
dc.type | Journal abstract | en_US |
Appears in Collections: | Department of Clinical Medicine |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.